Alzamend Neuro
ALZN
Alzamend Neuro (ALZN) earnings history
Most recent quarter
- Fiscal period
- Q1 2026
- Period end
- Jul 31, 2025
- EPS actual
- −$1.28
- EPS estimate
- −$2.08
- EPS surprise
- +38.46%
- Revenue surprise
- +0.00%
- Revenue
- $0.00
- Revenue estimate
- $0.00
- Reported
- Sep 10, 2025
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q1 2026 | Sep 10, 2025 | −$2.08 | −$1.28 | +38.46% | $0.00 | SEC |
| Q4 2025 | Jul 22, 2025 | −$2.70 | −$2.36 | +12.59% | $0.00 | SEC |
| Q3 2025 | Mar 10, 2025 | −$3.20 | −$1.71 | +46.48% | $0.00 | SEC |
| Q2 2025 | Dec 11, 2024 | −$3.60 | −$3.56 | +1.25% | $0.00 | SEC |
| Q1 2025 | Sep 11, 2024 | −$21.42 | −$11.25 | +47.48% | $0.00 | SEC |
| Q4 2024 | Jul 30, 2024 | −$34.20 | −$10.89 | +68.16% | $0.00 | SEC |
| Q3 2024 | Mar 25, 2024 | −$29.25 | −$34.20 | −16.92% | $0.00 | SEC |
| Q2 2024 | Dec 15, 2023 | −$46.80 | −$39.60 | +15.38% | $0.00 | SEC |
| Q1 2024 | Sep 13, 2023 | −$54.00 | −$51.30 | +5.00% | $0.00 | SEC |
Quarterly revenue
Frequently asked questions
When did Alzamend Neuro (ALZN) last report earnings?
Alzamend Neuro last reported on Sep 10, 2025, covering fiscal Q1 2026.
Did ALZN beat earnings estimates?
Yes. Alzamend Neuro reported EPS of −$1.28 for Q1 2026 against a −$2.08 estimate — a 38.46% beat.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.